Barlogie Figure 16.
Revimid
â
Phase III trial for relapsing myeloma (Arkansas 2001-44).
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal